Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-18 | 486.30 | 34.50 | 57.58p | 26.6 | 6.7 | +4% | 21.66p | 1.4% |
31-Mar-19 | 766.60 | 46.70 | 69.71p | 37.1 | 1.8 | +21% | 34.49p | 1.3% |
31-Mar-20 | 833.80 | 92.00 | 87.20p | 32.1 | 1.3 | +25% | 44.50p | 1.6% |
31-Mar-21 | 820.40 | 34.20 | 81.86p | 41.8 | n/a | -6% | 39.00p | 1.1% |
31-Mar-22 | 1,185.30 | (18.60) | 100.37p | 24.4 | 1.1 | +23% | 37.50p | 1.5% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-23 | 1,324.34 | 326.91 | 94.51p | 26.1 | n/a | -6% | 36.87p | 1.5% |
31-Mar-24 | 1,437.98 | 381.93 | 110.98p | 22.2 | 1.3 | +17% | 40.54p | 1.7% |
Copyright © 2022 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 26.62 | 24.41 | 32.42 | 0.76 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 2,463.00p |
Change Today | -11.00p |
% Change | -0.44 % |
52 Week High | 4,220.00 |
52 Week Low | 1,924.00 |
Volume | 240,393 |
Shares Issued | 301.62m |
Market Cap | £7,429m |
RiskGrade | 170 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 9 |
Buy | 1 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 2 |
Total | 18 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 07-Jul-22 | 06-Jan-22 |
Paid | 05-Aug-22 | 04-Feb-22 |
Amount | 24.50p | 13.00p |
Time | Volume / Share Price |
16:35 | 117,464 @ 2,463.00p |
16:29 | 42 @ 2,473.00p |
16:29 | 53 @ 2,473.00p |
16:29 | 111 @ 2,471.00p |
16:29 | 13 @ 2,471.00p |
Chair | Philip Aiken |
CEO | Peter Herweck |
You are here: research